Medicine

Nesrine El-Bizri is an Associate Principal Scientist at Merck Research Laboratories (MRL) in South San Francisco, USA. She has more than 20 years of combined PhD, Postdoctoral and biotechnology experience in the field of cardiovascular research with core expertise in in vitro, in situ and in vivo models of disease. She has a PhD in Cell Biology from the University of Sherbrooke, Quebec, Canada and has completed a Postdoctoral Fellowship in Pulmonary Arterial Hypertension at Stanford School of Medicine. She then joined Gilead in 2007 and extensively contributed to preclinical discovery research teams with focus on target validation, lead optimization and preclinical efficacy and safety research supporting the development of a molecule into phase 2/3 clinical trials in three different indications. In 2017, she joined MRL in early discovery cardiovascular group in the Department of Cardio-Renal Metabolic & Ophthalmic Discovery Biology where she is studying heart failure.